Sanofi produces Johnson & Johnson Covid-19 vaccines
Sanofi Pasteur’s new phase 2 study aims to determine final vaccine formulation for adults of all ages . “We are confident that our vaccination candidate has a strong potential,” says CEO Thomas Triomphe .
